Search 

Abacus Diagnostica Oy is a Finnish molecular diagnostics company specialized in rapid DNA testing utilizing its proprietary GenomEra™ technology.

Abacus Diagnostica provides reliable, pathogen specific, easy to use solutions to enable routine use of DNA based testing when infections with critical pathogens are suspected and high sensitivity is needed.

Abacus Diagnostica’s sales are organized through distributors, currently with partners in Finland and 8 other European countries. Totally 33 systems are already placed in Europe, of which half are in routine use. 

PRODUCTS AVAILABLE (CE-IVD):

• GenomEra CDX™ Analyzer System 
• GenomEra MRSA/SA Blood Culture Test Kit
• GenomEra MRSA/SA Nasal Swab Test Kit
• GenomEra MRSA/SA Multi Swab Test Kit
• GenomEra MRSA/SA Diagnose Test Kit
• GenomEra Clostridium difficile Test Kit (available for evaluation Sep 2012)

To accelerate sales and growth, Abacus is now seeking for a capital investment to be targeted on three main topics:

1. Boosting sales by accelerating Europe and entering the US market
2. Widening the the test kit portfolio,  and
3. Increasing production capacity both for test chips and analyzers. 

Company specialized in wireless and mobile solutions for monitoring, alarn and control wiithin health care and security markets.

We focus on eldercare and we already have thousands of users and have entered the growth phase. Major distribution deals have been signed in UK, NL, FR, SE, FI and will shortly be in US.

Looking to raise a total of 3 M in funding for the expansion and rapid growth.

Our leading product is the Vega GPS global solution with the wearable watch providing answers to 3 major challenges:

- protection always available

- always know where a person/wearer is

- interact with the users

eWELL Oy is a consultancy company specialized for the health and social care sector ICT and service solution innovation development and networks. Kalevi Virta has a long experience from the Finnish eco system, he has coordinated several major funding and development programmes and has excellent connections to different private companies, service providers and research organizations.

Greater Helsinki Promotion (GHP) enables dynamic international companies to create success within the heart of business in Finland, Russia and the Baltics. GHP is a non-profit organization, established by the cities of the capital region to drive high impact international investments into the region.

GHP works in close cooperation with key public and private sector partners, offering effortless access to the right information, best partners and business support.

Partner&distributor arrangement in Japan

We are looking for new innovative medtech products&solutions for the Japanese market.

Innomedica is an international business development company specialized in licensing, distributor search and strategic planning. We provide our services to  medical technology, biotechnology and health product companies in Europe and Japan.

The Japan market is the world’s second largest healthcare market after USA. Japan has a 130 millon population with one of the highest GDP’s in the world. And all citizens are covered by national health insurance.

Japan Market in numbers

• 250 000 doctors
• close to 10 000 hospitals (> 20 beds/hospital)
• 100 000 clinics
• Pharmaceutical sales $115 billion in 2011
• Medical device annual sales $24 billion
• IVD annual sales $3,5 billion
• 80% of medical facilities are privately owned
• Half of the medical devices available in Europe and USA are not available in Japan

Innomedica supports companies in following business operations:

• Tailor-made distribution arrangement and partnering operations
• Market analysis
• Strategic planning
• Business development
• Partner candidate screening
• Introduction and marketing meetings
• Negotiation support
• Agreement process
• Marketing communication
• PR
• Academic collaborations
• Translations
• Project management